# Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets

> **NCT07681544** · NA · COMPLETED · sponsor: **Hospital Italiano de Buenos Aires** · enrollment: 26 (actual)

## Conditions studied

- Empirical Antimicrobial Therapy
- Critically Ill
- Meropenem
- Pharmacokinetics and Pharmacodynamics

## Interventions

- **DIAGNOSTIC_TEST:** Blood extraction

## Key facts

- **NCT ID:** NCT07681544
- **Lead sponsor:** Hospital Italiano de Buenos Aires
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-26
- **Primary completion:** 2024-09-20
- **Final completion:** 2025-02-15
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681544, "Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07681544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*